Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gordon Alan Vehar is active.

Publication


Featured researches published by Gordon Alan Vehar.


Biochemical and Biophysical Research Communications | 1976

Functional arginine residues involved in coenzyme binding by dihydrofolate reductase.

Gordon Alan Vehar; James H. Freisheim

Abstract Reaction of dihydrofolate reductase from amethopterin-resistant Lactobacillus casei with phenylglyoxal results in a complete loss of enzyme activity. This inactivation is concomitant with the modification of five of a total of eight arginine residues per mole of enzyme. In the presence of the reduced coenzyme, NADPH, two of the five reactive arginines are protected from chemical modification with complete retention of enzyme activity. The results suggest the involvement of essential arginine residues at or near the coenzyme binding site and thus at or near the active center of the enzyme.


Biochemistry | 1986

Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity

Dan L. Eaton; Henry Rodriguez; Gordon Alan Vehar


Biochemistry | 1980

Preparation and properties of bovine factor VIII (antihemophilic factor)

Gordon Alan Vehar; Earl W. Davie


Biochemistry | 1986

Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule.

Dan L. Eaton; William I. Wood; Debbie Eaton; Philip E. Hass; Philip Hollingshead; Karen L. Wion; Jennie P. Mather; Richard M. Lawn; Gordon Alan Vehar; Cornelia M. Gorman


Biochemistry | 1987

Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis.

Keri M. Tate; Deborah L. Higgins; William Evans Holmes; Marjorie E. Winkler; Herbert L. Heyneker; Gordon Alan Vehar


Biochemistry | 1987

Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin

Deborah L. Higgins; Gordon Alan Vehar


Biochemistry | 1976

Reaction of dihydrofolate reductase with dansyl chloride. Chemical modification of a sensitive lysine residue and fluorometric studies of the dansylated enzyme.

Gordon Alan Vehar; Anthony V. Reddy; James H. Freisheim


Archive | 1985

Insight into biosynthesis of human urokinase forms

L. Flohe; Gerd J. Steffens; W. A. Gunzler; F. Otting; Herbert L. Heyneker; Kenneth C. Holmes; Michael Willard Rey; Peter H. Seeburg; Joel S. Hayflick; Gordon Alan Vehar


Molecular Cancer Therapeutics | 2007

KID24, an antibody directed against ADAM9, is a potent inhibitor of tumor growth in vivo.

Tony W. Liang; Mark Armanini; Young Peter; Pam Li; Gordon Alan Vehar; Jennie P. Mather


Archive | 1994

Recombinant expression vector expressing human urokinase and transformed cell

Herbert L. Heyneker; William Evans Holmes; Gordon Alan Vehar; ウィリアム・エバンス・ホウムズ; ゴードン・アラン・ヴィハー; ヘルベルト・ルイス・ヒンケル

Collaboration


Dive into the Gordon Alan Vehar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

William Evan Holmes

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge